Cardiovascular outcomes and safety with linagliptin, a dipeptidyl peptidase‐4 inhibitor, compared with the sulphonylurea glimepiride in older people with type 2 diabetes : A subgroup analysis of the randomized CAROLINA trial

Espeland, Mark A.; Mattheus, Michaela; Johansen, Odd Erik; McGuire, Darren K.; Pratley, Richard E.; Weber, Maria; Kadowaki, Takashi; Rosenstock, Julio; Seino, Yutaka; Andersen, Knut Robert; Zinman, Bernard; Marx, Nikolaus; Keller, Annett

doi:openalex:W3101372907

Mehr Informationen
Referenzen (0)
Diskussion (0)
Dateien

Cardiovascular outcomes and safety with linagliptin, a dipeptidyl peptidase‐4 inhibitor, compared with the sulphonylurea glimepiride in older people with type 2 diabetes : A subgroup analysis of the randomized CAROLINA trial - RWTH-CONV-244589

Ähnliche Datensätze

h1

h2

h3

h4

h5

h6

RWTH

Kontakt

RWTH Publications

Allgemeines